Cognitive-Behavioral Therapy and Trazodone for Sleep and Blood Pressure in Insomnia Subtypes
Official title: 2/2 Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia Phenotypes Based on Objective Sleep Duration: A Sequential Cohort/Randomized Controlled Trial
Funded at University of Pittsburgh at Pittsburgh · NIH-11416636 · Data updated 2026-11-12
This program tests how CBT-I and trazodone help sleep and blood pressure in adults with insomnia, focusing on those with short sleep duration versus normal sleep duration.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project start | July 1, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $455,087 |
| NIH project number | 5U24HL161359-04 |
| Project ID | NIH-11416636 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults aged 18 and older with insomnia and elevated blood pressure, stratified by ISS or INS sleep duration phenotype.
✕Less likely to help
Individuals without insomnia or with normal blood pressure elevation or those not meeting phenotype criteria may not benefit.
What this research studies
Insomnia is common and tied to higher risks for heart, metabolism, and mental health issues. The study zeroes in on a insomnia with short sleep duration (ISS) phenotype and compares its treatment response to insomnia with normal sleep duration (INS) when adults also have elevated blood pressure. It starts with a four-site observational cohort, then moves to a placebo-controlled randomized trial to test CBT-I and trazodone in 600 adults. The goal is to see if ISS and INS respond differently to these treatments, with CBT-I as the standard first-line therapy and trazodone as an additional option for non-responders. The research will measure sleep outcomes, blood pressure, and hormonal stress markers to guide future personalized insomnia care.
Why it matters
Potential benefit: If successful, patients with insomnia and high blood pressure could receive more effective, phenotype-guided treatments to improve sleep and cardiovascular health.
How similar studies have gone: Preliminary data suggest differential responses to CBT-I and trazodone by insomnia phenotype, supporting further testing in a larger trial.
Where this research is happening
-
University of Pittsburgh at Pittsburgh
Pittsburgh, United States Active
Researchers
- Principal investigator: Wisniewski, Stephen R — University of Pittsburgh at Pittsburgh
- Study coordinator: Wisniewski, Stephen R
Related research
Other NIH-funded projects on the same topics.
-
Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure
A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.
-
Insomnia subtypes and sleep meds: CBT-I and trazodone for adults with high blood pressure
We’re testing whether a sleep therapy (CBT-I) and the antidepressant trazodone help adults with insomnia and high blood pressure, especially those with the short-sleep-insomnia subtype.
-
Sleep therapy versus trazodone for short-sleep insomnia and high blood pressure
This project compares a talk-based sleep program (CBT-I) and the medication trazodone to help adults with insomnia who also have elevated blood pressure, especially those who sleep less at night.
-
Behavioral therapy and trazodone for insomnia types that affect sleep time and blood pressure
This research will compare cognitive behavioral therapy and the medication trazodone to help adults with insomnia and high blood pressure sleep more and lower their blood pressure.
-
Cognitive behavioral therapy and trazodone for insomnia-related short sleep and high blood pressure
This project compares talk-based sleep therapy and the medication trazodone to help adults with insomnia sleep longer and lower their blood pressure, especially if they sleep less than usual.
-
Effects of therapy and medication on sleep and blood pressure in people with insomnia
This study is looking at how two different treatments—Cognitive Behavioral Therapy for Insomnia (CBT-I) and the medication trazodone—can help improve sleep quality and lower blood pressure in adults who struggle with insomnia, especially those who don’t get enough sleep.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.